RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 78-88
  • Gilead counters AbbVie with exclusive hepatitis C drug deal of its own

     Gilead counters AbbVie with exclusive hepatitis C drug deal of its own
    CVS Health announced Monday that it plans to make Gilead Sciences' hepatitis C drugs the exclusive option for most of its consumers starting Wednesday. The announcement comes two weeks after Express Scripts, the nation's largest manager of prescription...
  • Biotech Company To Open Lab In Farmington

    CaroGen Corp. will establish a laboratory at UConn's Technology Incubation Program in Farmington to develop its vaccine technology research, the company is announcing Monday. The Hamden-based biotechnology company has four employees and hopes to grow to...
  • AbbVie lowers price of hepatitis C drug to win deal with Express Scripts

    AbbVie lowers price of hepatitis C drug to win deal with Express Scripts
    AbbVie has substantially cut the price of its newly approved hepatitis C drug to win an exclusive deal with Express Scripts, the nation's largest manager of prescription drug benefits, the companies said Monday. Starting Jan. 1, Express Scripts will stop...
  • Gilead shares plunge after Express Scripts spurns its $1,000 hepatitis C pill

    Gilead shares plunge after Express Scripts spurns its $1,000 hepatitis C pill
    Gilead Sciences Inc., already under fire for the high costs of its hepatitis C drugs, took another hit Monday when the nation's largest manager of pharmacy benefits struck an exclusive deal with a rival drugmaker. Express Scripts Holding Co. said Monday...
  • As Sales Lag For Breakthrough Vaccine, Senators Offer Aid

    MERIDEN — Connecticut's U.S. senators are trying to put public pressure on the Centers for Disease Control to buy flu vaccines from a local drug company, escalating Sen. Richard Blumenthal's private lobbying. The senators sent a letter to the CDC...
  • Few Allergan execs to keep top jobs in Actavis takeover

    Few Allergan execs to keep top jobs in Actavis takeover
    The soon-to-be owner of Irvine-based Allergan Inc. announced sweeping leadership changes that pass over many current executives including the Botox maker's CEO. Irish pharmaceutical giant Actavis expects to finalize its $66-billion acquisition in the...
  • Lawsuit accuses Ackman, Valeant of insider trading in Allergan stock

    Lawsuit accuses Ackman, Valeant of insider trading in Allergan stock
    A new lawsuit accuses hedge fund manager Bill Ackman and Canadian firm Valeant Pharmaceuticals International Inc. of insider trading in Allergan Inc. stock before their unsuccessful bid to acquire the Botox maker. The lawsuit was filed Wednesday on...
  • Los Angeles seafood company ordered shut over unsanitary conditions

    Los Angeles seafood company ordered shut over unsanitary conditions
    A Los Angeles seafood company specializing in smoked and pickled fish was ordered shut by a federal judge over unsanitary conditions. Neptune Manufacturing Inc. can’t reopen until it meets compliance with the U.S. Food and Drug Administration....
  • Dropping coverage of popular prescription drugs is sad and shameful

    Express Scripts, which handles prescription-drug benefits for millions or people nationwide, is dropping coverage for 66 brand-name drugs next month in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....
  • Use these 4 simple strategies to cut your drug spending

    Trying to save money on prescription drugs can be enough to make you reach for the pain pills. Navigating the annual changes to your health plan, figuring out insurance co-pays, and finding the pharmacy with the best buys can be daunting. And if you're on...
  • Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016

    Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
    A Northbrook company said it has won fast-track status for approval of a drug that could become the first in the United States to treat Duchenne muscular dystrophy, a fatal muscle disease found most often in boys. Privately held Marathon Pharmaceuticals...